7-[[5-(4-Fluorophenyl)sulfonyl-4-hydroxypentyl]-methylsulfonylamino]heptanoic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 7-[[5-(4-Fluorophenyl)sulfonyl-4-hydroxypentyl]-methylsulfonylamino]heptanoic acid
• 英文别名: 7-[[5-(4-fluorophenyl)sulfonyl-4-hydroxypentyl]-methylsulfonylamino]heptanoic acid
• 化学式: C₁₉H₃₀FNO₇S₂
• 分子量: 467.58
• InChiKey: LAHLCSSEFIEFCR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  30
• 可旋转键数：
  15
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.63
• 拓扑面积：
  146
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  ethyl 7-[N-(4,5-epoxypentyl)methanesulfonamido]heptanoate 在 ammonium molybdate 、 sodium hydroxide 、 双氧水 作用下， 以 乙醇 、 溶剂黄146 为溶剂， 生成 7-[[5-(4-Fluorophenyl)sulfonyl-4-hydroxypentyl]-methylsulfonylamino]heptanoic acid
  参考文献：
  名称：

  11,12-Secoprostaglandins. 5. 8-Acetyl- or8-(1-hydroxyethyl)-12-hydroxy-13-aryloxytridecanoic acids and sulfonamide isosteres as inhibitors of platelet aggregation

  摘要：

  The synthesis of a series of 8-acetyl- (or 1-hydroxyethyl-) 12-hydroxy-13-aryloxytridecanoic acids and their sulfonamide isosteres is described. These compounds are formally derived from members of earlier reported series of modified secoprostaglandins by replacing the omega-butyl chain termini by substituted aryloxy groups. A number of these compounds are potent inhibitors of collagen-induced blood platelet aggregation in guinea pigs on oral administration.

  DOI：

  10.1021/jm00208a003

文献信息

• 11,12-Secoprostaglandins. 5. 8-Acetyl- or8-(1-hydroxyethyl)-12-hydroxy-13-aryloxytridecanoic acids and sulfonamide isosteres as inhibitors of platelet aggregation
  作者：John B. Bicking、James H. Jones、Wilbur J. Holtz、Charles M. Robb、Frederick A. Kuehl、David H. Minsker、Edward J. Cragoe

  DOI：10.1021/jm00208a003

  日期：1978.10

  The synthesis of a series of 8-acetyl- (or 1-hydroxyethyl-) 12-hydroxy-13-aryloxytridecanoic acids and their sulfonamide isosteres is described. These compounds are formally derived from members of earlier reported series of modified secoprostaglandins by replacing the omega-butyl chain termini by substituted aryloxy groups. A number of these compounds are potent inhibitors of collagen-induced blood platelet aggregation in guinea pigs on oral administration.